Frontiers in Oncology | Cancer Immunity and Immunotherapy

Case Report

Published on 25 Nov 2022

Case report: A rare case of neutropenia caused by pembrolizumab in squamous lung cancer and literature review

in Cancer Immunity and Immunotherapy

Qiaoyun Tan
Lichao Liu
Yu Huang
Xiaorong Dong
Lingjuan Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.973421

3,527 views
5 citations

Original Research

Published on 24 Nov 2022

PET/CT radiomics for prediction of hyperprogression in metastatic melanoma patients treated with immune checkpoint inhibitors

in Cancer Immunity and Immunotherapy

H. S. Gabryś
L. Basler
S. Burgermeister
S. Hogan
M. Ahmadsei
M. Pavic
M. Bogowicz
D. Vuong
S. Tanadini-Lang
R. Förster

Frontiers in Oncology

doi 10.3389/fonc.2022.977822

3,090 views
5 citations

Review

Published on 24 Nov 2022

Recent advances in the progress of immune checkpoint inhibitors in the treatment of advanced gastric cancer: A review

in Cancer Immunity and Immunotherapy

Jingjing Shen
Zhongming Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.934249

3,387 views
10 citations

Original Research

Published on 22 Nov 2022

Anti-PD-L1/PD-L2 therapeutic vaccination in untreated chronic lymphocytic leukemia patients with unmutated IgHV

in Cancer Immunity and Immunotherapy

Uffe Klausen
Jacob Handlos Grauslund
Nicolai Grønne Dahlager Jørgensen
Shamaila Munir Ahmad
Merete Jonassen
Stine Emilie Weis-Banke
Evelina Martinenaite
Lone Bredo Pedersen
Thomas Landkildehus Lisle
Anne Ortved Gang

Frontiers in Oncology

doi 10.3389/fonc.2022.1023015

2,785 views
5 citations

Original Research

Published on 22 Nov 2022

The role of preoperative inflammatory markers in patients with central nervous system tumors, focus on glioma

in Cancer Immunity and Immunotherapy

Fan Chen
Min Chao
Tao Huang
Shaochun Guo
Yulong Zhai
Yuan Wang
Na Wang
Xuan Xie
Liang Wang
Peigang Ji

Frontiers in Oncology

doi 10.3389/fonc.2022.1055783

2,793 views
4 citations

Original Research

Published on 21 Nov 2022

Dynamic alterations in PD-1/PD-L1 expression level and immune cell profiles based on radiation response status in mouse tumor model

in Cancer Immunity and Immunotherapy

Yi Na Yoon
Min Ho Choe
Moonkyoo Kong
Weon Kuu Chung
Jae-Sung Kim
Yu Jin Lim

Frontiers in Oncology

doi 10.3389/fonc.2022.989190

3,064 views
2 citations

Case Report

Published on 21 Nov 2022

Case report: Complex paraneoplastic syndromes in thymoma with nephrotic syndrome, cutaneous amyloidosis, myasthenia gravis, and Morvan’s syndrome

in Cancer Immunity and Immunotherapy

Huiqin Liu
Zeqin Dong
Milan Zhang
Rui Pang
Jiajia Xu
Pan He
Wenli Mei
Shuai Zhang
Guanqiao You
Wei Li

Frontiers in Oncology

doi 10.3389/fonc.2022.1002808

3,576 views
6 citations

Original Research

Published on 21 Nov 2022

Myeloid cell reprogramming alleviates immunosuppression and promotes clearance of metastatic lesions

in Cancer Immunity and Immunotherapy

Ravi M. Raghani
Jeffrey A. Ma
Yining Zhang
Sophia M. Orbach
Jing Wang
Mina Zeinali
Sunitha Nagrath
Sandeep Kakade
Qichen Xu
Joseph R. Podojil

Frontiers in Oncology

doi 10.3389/fonc.2022.1039993

3,824 views
4 citations

Original Research

Published on 18 Nov 2022

Hypofractionated concurrent chemoradiotherapy related lymphopenia and its association with survival in locally advanced non-small cell lung cancer patients

in Cancer Immunity and Immunotherapy

FangJie Liu
YingJia Wu
JianHui Shao
Bo Qiu
SuPing Guo
QiaoTing Luo
JinYu Guo
DaQuan Wang
Chu Chu
Rui Zhou

Frontiers in Oncology

doi 10.3389/fonc.2022.979384

1,821 views
3 citations

Review

Published on 18 Nov 2022

ZHX2 in health and disease

in Cancer Immunity and Immunotherapy

Na Li
Zhuanchang Wu
Chunhong Ma

Frontiers in Oncology

doi 10.3389/fonc.2022.1038890

5,292 views
10 citations

Case Report

Published on 17 Nov 2022

Case report: Treatment of metastatic dedifferentiated chondrosarcoma with pembrolizumab yields sustained complete response

in Cancer Immunity and Immunotherapy

Amisha Singh
Steven W. Thorpe
Morgan Darrow
Janai R. Carr-Ascher

Frontiers in Oncology

doi 10.3389/fonc.2022.991724

4,526 views
8 citations

Editorial

Published on 17 Nov 2022

Editorial: Multiplexed image analysis for translational research project applications

in Cancer Immunity and Immunotherapy

Vera Luiza Capelozzi
Edwin Roger Parra

Frontiers in Oncology

doi 10.3389/fonc.2022.1089265

1,206 views
1 citation

Original Research

Published on 17 Nov 2022

Research trends on anti-PD-1/PD-L1 immunotherapy for esophageal cancer: A bibliometric analysis

in Cancer Immunity and Immunotherapy

Yuanyuan Yang
Feng Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.983892

3,838 views

Original Research

Published on 11 Nov 2022

A ferroptosis-related gene signature associated with immune landscape and therapeutic response in osteosarcoma

in Cancer Immunity and Immunotherapy

Xinxing Wang
Guang Xia
Shilang Xiao
Song Wu
Lina Zhang
Junjie Huang
Wenxiu Zhang
Xu Cao

Frontiers in Oncology

doi 10.3389/fonc.2022.1024915

5,770 views
10 citations

Original Research

Published on 10 Nov 2022

Characterization of the basement membrane in kidney renal clear cell carcinoma to guide clinical therapy

in Cancer Immunity and Immunotherapy

Xi Xiong
Chen Chen
Jun Yang
Li Ma
Xiong Wang
Wei Zhang
Yuan Yuan
Min Peng
Lili Li
Pengcheng Luo

Frontiers in Oncology

doi 10.3389/fonc.2022.1024956

3,393 views
9 citations

Review

Published on 10 Nov 2022

MSCs can be a double-edged sword in tumorigenesis

in Cancer Immunity and Immunotherapy

Lu Zhang
Junyu Xiang
Fang Zhang
Limei Liu
Chongling Hu

Frontiers in Oncology

doi 10.3389/fonc.2022.1047907

3,417 views
20 citations